Outlook Therapeutics, Inc.

DB:41O Stock Report

Market Cap: €44.3m

Outlook Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:41O Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Sep 24Buy€25,451Lawrence KenyonIndividual5,000€5.09

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 41O?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders76,2120.234%
Private Companies2,537,2897.78%
Institutions6,783,47620.8%
VC/PE Firms9,266,64528.4%
General Public13,956,55542.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 40%.

Top Shareholders

Top 25 shareholders own 56.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
28.4%
GMS Ventures & Investments
9,266,645€12.6m59.6%no data
5.23%
Syntone Technologies Group Co. Ltd.
1,705,438€2.3m0%no data
4.89%
Armistice Capital LLC
1,595,427€2.2m0%0.06%
3.81%
BlackRock, Inc.
1,242,372€1.7m13.6%no data
2.63%
Sphera Funds Management Ltd
857,142€1.2m107%0.21%
2.61%
The Vanguard Group, Inc.
852,540€1.2m-0.39%no data
2.55%
GMS Tenshi Holdings Pte. Limited
831,851€1.1m0%no data
1.06%
Geode Capital Management, LLC
347,229€472.1k1.54%no data
0.88%
UBS Asset Management AG
286,644€389.7k3,910%no data
0.76%
State Street Global Advisors, Inc.
248,596€338.0k6.9%no data
0.56%
Tang Capital Management, LLC
182,502€248.1k-88.3%0.02%
0.56%
FMR LLC
181,519€246.8k17,800%no data
0.46%
Woodline Partners LP
151,508€206.0k0%no data
0.4%
Renaissance Technologies LLC
130,374€177.2k0%no data
0.34%
Northern Trust Global Investments
111,750€151.9k-5.99%no data
0.25%
Susquehanna International Group, LLP, Asset Management Arm
81,275€110.5k0%no data
0.23%
Scotiabank Global Banking and Markets, Asset Management Division
74,039€100.7k0.07%no data
0.18%
AQR Capital Management, LLC
59,174€80.4k0%no data
0.14%
Morgan Stanley, Investment Banking and Brokerage Investments
45,886€62.4k10.8%no data
0.12%
Goldman Sachs Group, Investment Banking and Securities Investments
38,993€53.0k0%no data
0.11%
Jeffrey Evanson
37,298€50.7k0%no data
0.11%
Charles Schwab Investment Management, Inc.
36,048€49.0k0%no data
0.08%
Jane Street Group, LLC, Asset Management Arm
26,218€35.6k134%no data
0.079%
Commonwealth Equity Services, LLC
25,615€34.8k0%no data
0.073%
Barclays PLC Private Banking & Investment Banking Investment
23,880€32.5k14%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/12 06:26
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Outlook Therapeutics, Inc. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Brian Kemp DolliverBrookline Capital Markets
Kumaraguru RajaBrookline Capital Markets